Dr. Jens Wiehler

BioM Biotech Cluster Development GmbH, Managing Director DigiMed Bayern

Jens joined Bio^M in early 2018 to help setting up the Bavarian P4 medicine flagship project DigiMed Bayern. Since it’s start he is heading DigiMed Bayern operational part as Managing Director. The project aims to implement digitally driven predictive, preventive, personalized and participatory medicine of the future in the examplary field of atherosclerotic diseases. It is funded by the Bavarian State Ministry of Health and Care with a total of above € 24 Mio with runtime until 2024.

In addition, Jens supports Bio^M and the Bavarian Biotech Cluster with his expertise in international Business Development and Digital Health.

2006 to 2018 he was responsible for setting up and scaling DNA-related services within different companies of the Eurofins group. This comprised DNA-Forensics, ancestry and paternity testing as well as animal and plant breeding, food analysis and cell genotyping. 2001 to 2006 he worked in Sales and Product Management for the Munich area based SME Biomax Informatics AG.

Jens has a PhD in Protein Engineering from the Gene Center of the Ludwig Maximilian University of Munich and a Diploma in Biology (Population Genetics) from Christian-Albrechts-Universität zu Kiel.